The Filing Desk

Mativ

MATV · NYSE · Materials · Financials, fiscal 2016 to 2025

MATV · Last close · November 13, 2026
$11.79
Value Mativ yourself

Mativ's revenue rose 0.3% to $2.0 billion in fiscal 2025. Its operating margin was −19.4%, down from 0.3% a year earlier. Free cash flow was $94 million, up 135.7%. It paid out $22 million in dividends and buybacks, 24% of free cash flow. The diluted share count rose 0.5%.

MATIV HOLDINGS, INC. Latest fiscal year ended December 31, 2025 10-K filed February 26, 2026 · 0001000623-26-000016 Updated
Revenue
$2.0B
0.3%
Operating margin
−19.4%
19.7 pts
Net income
−$337M
 
Free cash flow
$94M
135.7%
Return on capital
−18.1%
18.3 pts
Market cap
$651M
Nov 13 close
P/E
7.1x
On $1.66 EPS, 4 qtrs

Operating margin is operating income as a share of revenue. Free cash flow is cash from operations minus capital spending. Return on capital is after-tax operating income as a share of the money invested in the business: debt plus equity, minus cash. Market cap is the last closing share price times the latest diluted share count, so it is approximate. P/E is the last close divided by diluted earnings per share over the last four quarters, or the latest fiscal year where the quarters aren't available; there is none when the company made a loss.

About these figures. Net debt to EBITDA for fiscal 2025 is blank: the 10-K's structured data doesn't include every figure it needs.

Charts show fiscal years, from the 10-K filings.

What Mativ does

Mativ makes specialty materials for other businesses, combining polymers, fibers and resins to improve its customers' products. It sells into markets such as filtration, healthcare and packaging. It was spun off from Kimberly-Clark in 1995 and was known as Schweitzer-Mauduit until its 2022 merger with Neenah.

It has two reporting segments. Filtration and Advanced Materials focuses mainly on filtration media and components, advanced films, coating and converting solutions, and extruded mesh products. Sustainable and Adhesive Solutions focuses mainly on tapes, labels, liners, specialty paper, packaging and healthcare solutions. Its products are sold around the world, most of all in North America and Europe.

The company manufactures on three continents, does business in over 100 countries and runs 34 production locations. In November 2023 it sold its Engineered Papers business, which made tobacco-related papers, and so it no longer takes part in tobacco-based product markets. That business is shown as a discontinued operation.

Its biggest risks, as it describes them

  • Its technological advantages may not last, and its patents and other intellectual property may be challenged.
  • International risks from selling and making goods in many countries, including exchange rates and trade rules.
  • Further impairment of goodwill, which would reduce its reported results.
  • Trouble integrating acquisitions, and restructuring that is costly and could disrupt its business.
  • Loss or interruption of the operations of its facilities, and weaker construction and infrastructure spending.
From Mativ's annual report on Form 10-K, filed February 26, 2026, in our words; the 10-K has the full description and every risk factor. Updated with each new annual report.

Income statement

Revenue and net income
US$ billions, fiscal years; net losses in red. Revenue on the left axis, net income on the right; zero is the same line on both.
Revenue (left axis)Net income (right axis)
Gross profit, R&D and operating income
US$ billions, fiscal years. Gross profit is revenue minus the cost of what was sold; research and development is one of the costs paid from it; what remains after all operating costs is operating income. Losses in red.
Gross profitResearch and developmentOperating income
Margins
Percent of revenue
GrossOperatingNetFree cash flow

From fiscal 2016 to 2021, earnings per share grew 0.7% a year and net income 1.4% a year, as new shares raised the share count by 3% and diluted each share's earnings. Mativ then lost money in fiscal 2022, 2023, 2024 and 2025.

Diluted earnings per share
US$ per share, fiscal years, restated for any stock splits; loss years in red.

Returns on capital

Return on capital and on equity
Percent. Return on capital is after-tax operating income over the money invested in the business (debt plus equity, minus cash); return on equity is net income over shareholders' equity. Both use the average of opening and closing balances.
Return on capitalReturn on equity

Balance sheet

Cash and debt
US$ billions, at each fiscal year end. Debt includes finance leases.
Cash and short-term investmentsDebt
Assets, liabilities and equity
US$ billions, at each fiscal year end. Assets equal liabilities plus equity; negative equity in red.
Total assetsTotal liabilitiesShareholders' equity
Debt and liquidity ratios
Times. Debt to equity, current assets over current liabilities, and net debt over EBITDA (a full year's).
Debt to equityCurrent ratioNet debt to EBITDA

Five years at a glance

Fiscal year endFY21FY22FY23FY24FY25
Cash and short-term investments711011209484
Debt incl. finance leases1,2891,7421,1481,1311,052
Net debt (negative means net cash)1,2181,6411,0281,036967
Net debt to EBITDA23.9x23.5x—6.9x—
Debt to equity1.9x1.5x1.2x1.3x2.1x
Interest coverage−0.4x−0.7x−6.7x0.1x−5.4x
Current ratio2.6x2.1x2.5x2.4x2.2x
Quick ratio1.4x1.2x1.3x1.1x1.1x
US$ millions unless stated, at each fiscal year end. Net debt to EBITDA is debt minus cash, divided by operating income before depreciation and amortization: roughly how many years of those earnings the net debt equals. Debt to equity is debt as a multiple of shareholders' equity. Interest coverage is operating income divided by interest expense. The current ratio is current assets over current liabilities; the quick ratio leaves out inventory.

Cash flow

Cash from operations, capital spending and free cash flow
US$ billions, fiscal years. Free cash flow is cash from operations minus capital spending; negative years in red.
Cash from operationsCapital spendingFree cash flow
Stock-based compensation and buybacks
US$ billions, fiscal years. Shares paid to employees (stock-based compensation, a cost that uses no cash) against cash spent buying shares back. Buybacks that only match it leave the share count roughly where it was.
Stock-based compensationShare buybacks
Dividends and buybacks
US$ billions, cash paid in each fiscal year
DividendsShare buybacks
Diluted share count
Weighted-average diluted shares, millions

Projections

Project Mativ's revenue, net income and earnings per share five years ahead in a bull, a base and a bear case with your own figures, and see the share prices your P/E estimates give them, or value it with a discounted cash flow model. Every projected figure is yours: it is not a forecast of ours.

Insider trades

No officer, director or 10% owner of Mativ reported buying or selling its shares on the open market between November 14, 2025 and November 13, 2026.

From Form 4 filings with the SEC. Grants, option exercises and shares withheld for tax aren't counted. Insider trades at all companies

Indicators

Four widely used measures, worked out from the company's filings. The cutoffs are the ones their authors or users go by, not a verdict of ours.

IndicatorFY23FY24FY25
Piotroski F-score4 of 96 of 93 of 9
Rule of 4025.8%−0.2%5.0%
Altman Z''0.901.83−0.10
Accruals ratio−13.2%−5.6%−20.9%
Piotroski F-score: how many of nine simple tests of profitability, funding and efficiency the company passed in the year (Piotroski, 2000); 8 or 9 is strong, 0 to 2 weak. Rule of 40: revenue growth plus free cash flow margin; software investors treat 40% or more as the bar. Altman Z'': working capital, retained earnings, operating income and equity weighed against assets and liabilities (Altman, 1995); Altman puts above 2.6 in the safe zone and below 1.1 in the distress zone. Accruals ratio: net income minus cash from operations, over average total assets; lower means profit is backed by cash.

The nine F-score tests

TestFY23FY24FY25
Net income is positiveFailFailFail
Cash from operations is positivePassPassPass
Return on assets roseFailPassFail
Cash from operations exceeds net incomePassPassPass
Debt fell relative to assetsPassFailFail
Current ratio rosePassFailFail
Share count didn't riseFailPassFail
Gross margin roseFailPassFail
Revenue rose relative to assetsFailPassPass
F-score4 of 96 of 93 of 9
Companies that report no gross profit are scored on the other eight.

Compare

Put Mativ side by side with any other company we cover: revenue, growth, margins, cash flow and returns, with ten years of charts.

Similar companies

CompanyYearRevenue growthOperating marginFree cash flow marginReturn on capitalNet debt to EBITDAF-scoreCompare
MativFY250.3%−19.4%4.7%−18.1%—3
MagneraFY25—0.2%1.1%—−1.4x—Compare
SonocoFY2541.7%13.5%4.6%9.4%2.6x5Compare
Graphic PackagingFY25−2.2%9.3%−0.9%7.3%4.0x4Compare
Avery DennisonFY251.1%—8.0%14.6%2.5x5Compare
Each company's latest fiscal year. Fiscal years end in different months, so the periods don't line up exactly. Free cash flow margin is free cash flow as a share of revenue. Net debt to EBITDA is explained under the balance sheet, and the F-score under Indicators.

10 years of figures

Fiscal yearFY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Income statement
Revenue8409821,0411,0231,0749311,6372,0261,9811,987
Revenue growth9.9%16.9%6.0%−1.8%5.0%−13.4%75.9%23.8%−2.2%0.3%
Gross profit258283278290308183306356364363
Research and development18181514141219212324
Operating income110128135134129−16−40−4146−384
Net income833494868489−7−310−49−337
Diluted EPS (US$)2.701.123.062.762.662.80−0.18−5.69−0.90−6.19
Diluted shares (millions)30303131313142545455
Cash flow
Cash from operations1301311391601625820210795134
Capital expenditure28372729301946665540
Free cash flow1029411213213239157414094
Dividends paid49525354555572552222
Share buybacks11311371100
Acquisitions029200169630462000
Stock-based compensation67589820101111
Balance sheet at fiscal year end
Cash and short-term investments1071079410355711011209484
Debt incl. finance leases4476926375556011,2891,7421,1481,1311,052
Total assets1,1741,5421,4661,4721,5852,4203,6692,6422,4482,052
Total liabilities6659969098749351,7382,4901,6931,5891,553
Shareholders' equity5085475585986506821,179949858499
Margins and ratios
Gross margin30.7%28.9%26.8%28.4%28.7%19.7%18.7%17.6%18.4%18.3%
Operating margin13.1%13.1%13.0%13.1%12.0%−1.7%−2.5%−20.4%0.3%−19.4%
Net margin9.9%3.5%9.1%8.4%7.8%9.6%−0.4%−15.3%−2.5%−17.0%
Free cash flow margin12.1%9.6%10.8%12.9%12.2%4.2%9.6%2.0%2.0%4.7%
Rule of 40 (growth + FCF margin)22.1%26.5%16.8%11.1%17.3%−9.2%85.5%25.8%−0.2%5.0%
Return on capital10.7%6.5%11.0%10.5%9.3%−0.8%−1.4%−13.6%0.3%−18.1%
Return on equity17.0%6.5%17.1%14.8%13.4%13.3%−0.7%−29.1%−5.4%−49.7%
Return on assets6.7%2.5%6.3%5.8%5.5%4.4%−0.2%−9.8%−1.9%−15.0%
Net debt to EBITDA2.2x3.1x2.8x2.4x2.8x23.9x23.5x—6.9x—
US$ millions unless stated. Where a later 10-K restated a year, the latest filed figure is shown. Download all figures (CSV, US$ millions)
Source: Mativ's Form 10-K filings, from SEC EDGAR. For information only, not investment advice. The Filing Desk is not affiliated with Mativ.